Global burden of blood-pressure-related disease, 2001

被引:1817
作者
Lawes, Carlene M. M. [1 ]
Vander Hoorn, Stephen [1 ]
Rodgers, Anthony [1 ]
机构
[1] Univ Auckland, Clin Trials Res Unit, Auckland 1, New Zealand
关键词
D O I
10.1016/S0140-6736(08)60655-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Few studies have assessed the extent and distribution of the blood-pressure burden worldwide. The aim this study was to quantify the global burden of disease related to high blood pressure. Methods Worldwide burden of disease attributable to high blood pressure (>= 115 mm Hg systolic) was estimated for groups according to age (>= 30 years), sex, and World Bank region in the year 2001. Population impact fractions were calculated with data for mean systolic blood pressure, burden of deaths and disability-adjusted life years (DALYs), and relative risk corrected for regression dilution bias. Findings Worldwide, 7.6 million premature deaths (about 13.5% of the global total) and 92 million DALYs (6.0% of the global total) were attributed to high blood pressure. About 54% of stroke and 47% of ischaemic heart disease worldwide were attributed to high blood pressure. About half this burden was in people with hypertension; the remainder was in those with lesser degrees of high blood pressure. Overall, about 80% of the attributable burden occurred in low-income and middle-income economies, and over half occurred in people aged 45-69 years. Interpretation Most of the disease burden caused by high blood pressure is borne by low-income and middle-income countries, by people in middle age, and by people with prehypertension. Prevention and treatment strategies restricted to individuals with hypertension will miss much blood-pressure-related disease.
引用
收藏
页码:1513 / 1518
页数:6
相关论文
共 42 条
[1]  
[Anonymous], 2003, The world health report 2003: shaping the future
[2]  
[Anonymous], 2002, RED RISKS PROM HLTH
[3]   BLOOD-PRESSURE IN 4 REMOTE POPULATIONS IN THE INTERSALT STUDY [J].
CARVALHO, JJM ;
BARUZZI, RG ;
HOWARD, PF ;
POULTER, N ;
ALPERS, MP ;
FRANCO, LJ ;
MARCOPITO, LF ;
SPOONER, VJ ;
DYER, AR ;
ELLIOTT, P ;
STAMLER, J ;
STAMLER, R .
HYPERTENSION, 1989, 14 (03) :238-246
[4]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[5]   BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .2. SHORT-TERM REDUCTIONS IN BLOOD-PRESSURE - OVERVIEW OF RANDOMIZED DRUG TRIALS IN THEIR EPIDEMIOLOGIC CONTEXT [J].
COLLINS, R ;
PETO, R ;
MACMAHON, S ;
HEBERT, P ;
FIEBACH, NH ;
EBERLEIN, KA ;
GODWIN, J ;
QIZILBASH, N ;
TAYLOR, JO ;
HENNEKENS, CH .
LANCET, 1990, 335 (8693) :827-838
[6]   PLASMA-LIPIDS, LIPOPROTEINS, AND DIET OF TARAHUMARA INDIANS OF MEXICO [J].
CONNOR, WE ;
CERQUEIRA, MT ;
CONNOR, RW ;
WALLACE, RB ;
MALINOW, MR ;
CASDORPH, HR .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 1978, 31 (07) :1131-1142
[7]   Quantifying risk of death and disability associated with raised blood pressure [J].
Elliott, P ;
Nichols, R ;
Chee, D .
CLINICAL AND EXPERIMENTAL HYPERTENSION, 1999, 21 (5-6) :571-582
[8]   Selected major risk factors and global and regional burden of disease [J].
Ezzati, M ;
Lopez, AD ;
Rodgers, A ;
Vander Hoorn, S ;
Murray, CJL .
LANCET, 2002, 360 (9343) :1347-1360
[9]   Estimates of global and regional potential health gains from reducing multiple major risk factors [J].
Ezzati, M ;
Vander Hoorn, S ;
Rodgers, A ;
Lopez, AD ;
Mathers, CD ;
Murray, CJL .
LANCET, 2003, 362 (9380) :271-280
[10]  
He J, 1991, Epidemiology, V2, P88, DOI 10.1097/00001648-199103000-00002